MINUTES OF PROCEEDINGS OTTAWA, Wednesday, September 18, 2024 (110) [English] The Standing Senate Committee on Social Affairs, Science and Technology met this day at 4:15 p.m., in room B45, Senate of Canada Building, the chair, the Honourable Ratna Omidvar, presiding. Members of the committee present: The Honourable Senators Bernard, Brazeau, Burey, Cordy, Cormier, Dasko, Mégie, Moodie, Omidvar, Osler, Petitclerc and Seidman (12). Other senators present: The Honourable Senators Boudreau, Cardozo, Kingston and Senior (4).

Participating in the meeting: Mayra Perez-Leclerc and Kelly Farrah, analysts, Library of Parliament. Pursuant to the order of reference adopted by the Senate on Tuesday, June 18, 2024, the committee began its study of Bill C-64,

An Act respecting pharmacare. APPEARING: The Honourable Mark Holland, P.C., M.P., Minister of Health. WITNESSES: Health Canada: Michelle Boudreau, Associate Assistant Deputy Minister, Health Policy Branch; Daniel MacDonald, Director General, Office of Pha rmaceuticals Management Strategies, Health Policy Branch. Pan-Canadian Pharmaceutical Alliance: Dominic Tan, Acting Chief Executive Officer (by videoconference). Canada's Drug Agency: Suzanne McGurn, President and Chief Executive Officer.

Office of the Parliamentary Budget Officer: Yves Giroux, Parliamentary Budget Officer; Diarra Sourang, Director, Economic Analysis. The Honourable Mark Holland made a statement and answered questions. At 5:15 p.m., the committee suspended. At 5:18 p.m., the committee resumed. Suzanne McGurn, Dominic Tan and Yves Giroux each made a statement and, together with Diarra Sourang, answered questions. At 6:15 p.m., the committee adjourned to the call of the chair. ATTEST: Emily Barrette Clerk of the Committee